TrialStroke2010

The beta-hCG+erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trial.

Steven C Cramer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.